Skip to content

The effect of foot reflexology massage on stress and neuropathic pain induced by chemotherapy

A comparison between the effects of application versus non-application of foot reflexology massage on stress and neuropathic pain induced by chemotherapy in women with breast cancer and genital organs

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017090517756N28
Enrollment
60
Registered
2017-09-19
Start date
2017-05-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: breast cancer. Condition 2: Genital tract cancer. Carcinoma in situ of breast Female genital organ, unspecified

Interventions

Intervention 1: Intervention Group (Foot reflexology message): Prior to the intervention, demographic characteristics form, Perceived Stress Scale (Cohen et al., 1983), and the Leeds Assessment of Neu
Intervention Group (Foot reflexology message): Prior to the intervention, demographic characteristics form, Perceived Stress Scale (Cohen et al., 1983), and the Leeds Assessment of Neuropathic Symptom
Control Group (No intervention): Prior to the intervention, demographic characteristics form, Perceived Stress Scale (Cohen et al., 1983), and the Leeds Assessment of Neuropathic Symptoms and Signs Pa

Sponsors

Vice-chancellery for Research, Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Definitive diagnosis of breast cancer; malignancy based on pathological studies, clinical findings, and physician diagnosis; women treated with Taxon; age between 18 and 60 years; neuropathic pain induced by chemotherapy with a score of 12 or more according to the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale; reading and writing literacy and the ability to speak for the patient or caregiver; having healthy limbs in the legs, especially the sole of the legs or lack of sensory and motor disorders; no drug abuse; non-use of psychotropic drugs; no history of mental illness; informed consent for participation; and the use of prophylaxis drugs for neuropathic pains such as gabapentin and pre-cabalin. Exclusion criteria: Metastasis for bone marrow, lung, liver and kidneys; patient's lack of cooperation until the end of the intervention; and the presence of stressors such as the death of first-degree relatives, divorce, and severe changes in lifestyle over the past 6 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Perceived stress. Timepoint: before intervention and 2 weeks after intervention is completed. Method of measurement: Cohen et al.’s Perceived Stress Scale.;Neuropathic pain severity. Timepoint: before intervention and 2 weeks after intervention is completed. Method of measurement: The Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Hosain Rezaei Mohebbati

Birjand University of Medical Sciences

SHRM37@YAHOO.COM+56 32224687

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026